First-line IO-based combinations provide clinically meaningful survival in sRCC, with outcomes affected by sex, metastatic sites, and IMDC risk. This RWE may support a tailored therapeutic approach on ...
This post was updated March 31 at 11:21 p.m. UCLA researchers developed a human stem cell-derived cell therapy for an ...
Delta-like protein 1 (DLK1) is an enigmatic member of the epidermal growth factor-like family that plays a pivotal role in regulating cell proliferation, differentiation and tissue development. Acting ...
CD8 + cytotoxic T lymphocytes (CTLs) serve as central effectors in cancer immunotherapy by directly eliminating tumor cells. However, current clinical therapies face significant limitations. These ...
Scientists have discovered how two transcription factors form a reciprocal regulatory circuit that controls T-cell exhaustion ...
Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a biotechnology company pioneering the development of targeted genetic medicines, will present new data at the American ...
A team of researchers at Baylor College of Medicine, St. Jude Children's Research Hospital, Texas Children's Hospital and ...
To survive in ever-changing conditions in the body, cancer cells often need to alter their metabolism. 1 This ability to adapt is especially critical for their spread to other parts of the body. “This ...
Presentations showcase progress in BioNTech’s late-stage lung cancer programs, reinforcing the potential of the Company’s differentiated portfolio spanning immunomodulators, antibody-drug conjugates, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results